**Company No: 2270807 Registered Charity No: 800419** 

## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED** 

(A COMPANY LIMITED BY GUARANTEE) 

**REPORT AND ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2023** 



**THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED CONTENTS OF THE ACCOUNTS** 

||Page No.|
|---|---|
|Report of the Trustees|1 –10|
|Statement of Financial Activities|11|
|Balance Sheet|12|
|Cash Flow Statement|13|
|Notes to the Accounts|14 – 29|
|Independent Examiner’s Report|30|





**THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED TRUSTEES’ REPORT** 

**FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **INTRODUCTION** 

The Board of Directors, who are the charity trustees for the purposes of the Charities Act 2011, present their Annual Report for the year ended 31 December 2023 under the Companies Act 2006 and the Charities Act 2011, together with the financial statements for the year. The Board confirms that the latter comply with the requirements of the Companies Act 2006, the Company’s Memorandum and Articles of Association and the Charities SORP (FRS102). 

## **PURPOSES AND AIMS** 

The charity’s purposes and aims as set out in the Company’s Memorandum of Association are to aid and improve for the public benefit the condition of those living with Multiple Sclerosis (MS). 

MS is a neurological condition that is unpredictable, incurable and widely variable. With many symptoms including, but not limited to, loss of limb control (which may require a wheelchair/mobility aid), balance problems, fatigue (all-consuming tiredness), memory problems, pain, blurred vision, depression and incontinence. Its impact is often huge. Its complex nature means that specialist support is essential to manage symptoms and improve quality of life. 

The charity exists to support people with Multiple Sclerosis and to ease the impact it has on their, and their loved ones’, lives. 

## **STRATEGIES TO ACHIEVE OUR AIMS** 

The charity seeks to achieve these aims by 

- providing a range of treatments and therapies in an understanding environment where people can support and learn from each other. 

- making up-to-date information available and shared from reputable sources. 

The charity supports people living across Berkshire and the neighbouring counties of Oxfordshire, Hampshire, Surrey and Buckinghamshire. 

Without the Berkshire MS Therapy Centre the availability of treatments and therapies would be limited within the local area, in some cases non-existent. 

Ensuring the work delivers the charity’s aims 

The trustees have referred to the guidance contained in the Charity Commission’s general guidance on public benefit when reviewing the charity’s purposes and aims, and when planning future activities. In particular how planned activities will contribute to the achievement of the objectives and aims. 

## **Principal activities** 

The principal activities of the charity comprises three broad elements: 

- Core treatments and services including physiotherapy and exercise classes, oxygen therapy, footcare and counselling. 

- Complementary treatments including massage, acupuncture, spinal reflexology and reiki. 

- A supportive network for members 

Page 1 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED TRUSTEES’ REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **ACHIEVEMENTS AND PERFORMANCE 2023** 

Achievement of the aims and activities is measured by the range of treatments, services and support offered, the number of treatments provided and feedback from recipients. 

**"Joining the Centre was the best thing I ever did and I wouldn't still be on my feet now."** _Member feedback, 2023_ 

2023 was a busy year at the Berkshire MS Therapy Centre. The charity provided an unprecedented number of treatments, launched a new strategy and expanded new areas of support. 

In 2023, the Centre provided 14,395 treatments, a 32% increase compared with 10,927 treatments in 2022 (which itself was a record). In 2023 we supported 387 people (2022:336). The increase was particularly significant for physiotherapy, counselling and relaxation and mindfulness sessions. 

This growth can be attributed to several things: 

- Increased provision with more physiotherapy hours, more oxygen sessions, additional mindfulness courses and counselling appointments 

- Improved awareness of the Centre led by the charity's Membership and Volunteer Officer and Engagement and Marketing Officer. The return of the charity’s MS Steering Group resulted in improved communications with other relevant organisations, including local MS Society branches and MS healthcare professionals. 

- Continuation of online sessions alongside the in-person provision, which enabled members to attend more sessions. 

The Centre's social area has thrived, and the charity would especially like to thank the Aviva Community Fund, Berkshire Community Foundation, Co-op and Wokingham United Charities for supporting our 'Warm Winter' initiative. 

A successful application to the CAF Resilience Fund in 2021 helped the charity make a sizable investment into its long-term strategic and fundraising development, as well as in a number of the charity’s back-end functions. BMSTC  has emerged with a five year organisational strategy incorporating fundraising and communications structure to help us achieve our goals. 

The Trustees would like to thank everyone involved in this project and would especially like to acknowledge the significant contribution of Penny Tillson. 

There are four outcomes the charity would like to see resulting from this work: 

- Improved mental health and emotional wellbeing 

- Improved physical health and symptom management 

- Improved support for carers 

- Members feeling increased empowerment to manage their MS and make decisions about their support, life and condition. 

Over the next five years the charity will work towards the following key objectives: 

1. Increased number of people using our services 

2. Increased structured peer support and social interaction opportunities 

3. More people helped to navigate the information they need to manage their MS 

4. Make best use of our assets and resources, maintain our operational stability and  embrace growth 

5. Strengthen our commitment to inclusivity in the way we work 

Page 2 



**THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED TRUSTEES’ REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

In 2023 the charity said goodbye to a number of long-standing Trustees who collectively provided over 80 years of service to our Trustee Board: 

- Peter Bowsher 

- Mark Farnell 

- Ian Langrish 

- Dave Robson 

The contribution each has made is incalculable and the Centre would not be in such a strong position today without them. The Trustees would like to thank them on behalf of the charity. 

The charity has been pleased to welcome new trustee board members who bring a range of expertise to take the charity forward. 

- Sue Brown 

- Gregg Burgess-Salisbury 

- Imogen Fletcher 

- Daniela Hanuskova 

- Ashley Harrison 

- Ros Hatt 

- Nick Webb 

The charity welcomes the appointments of Neil Dawkins as Chairman and Ashley Harrison as Secretary. David Coe remains Treasurer. 

The charity has also seen a number of staff changes and has had to say goodbye to Kirsten Shakeri, Joy Tate and Kim Williams. The Trustees thank them for their hard work. We have welcomed Tamzin Cordery to the team. Further recruitment has taken place in the new year. 

The year ended with the launch of the new Berkshire MS Therapy Centre website and availability of physiotherapy and relaxation videos to improve support for  those who are unable to attend the Centre. The Trustees thank Penny Bird, Ben and the team at Southmedia, and Ben and Abdul at BMCreative for making these developments possible. The charity is very grateful to the CAF Resilience Fund, the Light Fund and AbbVie for their generous financial support. 

## **The difference the Centre makes:** 

The Centre received the following feedback in 2023: 

- Only 3% feel confident about getting the support they need without the Centre. 

- 100% would recommend the Centre to other people with MS 

- 98% of our members feel the Centre's support helps them feel happier 

- 99% of our members feel the Centre's support helps to improve their quality of life 

- 96% of our members feel the Centre's support helps their physical wellbeing 

- 91% of our members feel the Centre's support helps their mental wellbeing 

- 100% of our members tell us the Centre is a place where people understand 

- 90% of our members tell us the Centre's support makes them feel more connected and less lonely 

- 75% of our members who are still in work tell us the Centre helps them remain in employment 

Page 3 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED TRUSTEES’ REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

Here is what our members had to say: 

_‘I found [counselling] very helpful as I was struggling mentally and emotionally but now I have ways of coping and managing my emotions and feelings. I now find myself looking forward to the future and not worrying about it.’_ 

_‘I love the friendliness around physio and oxygen therapy and all the extra information that can be obtained from other users to help you.’_ 

_‘The benefit of social interaction at the Centre is not to be underestimated - everyone understands what having MS can entail.’_ 

_‘The physio support is second to none. The foot care is amazing and the whole atmosphere at the Centre is very welcoming’_ 

The Centre continues to be dependent on fundraising, donations, volunteers and grants to provide its vital services. 

The Trustees would like to thank everyone who supported the charity in 2023. The success of the year is the result of the combined participation of everyone who joined our services, and who donated, fundraised and volunteered. 

2023 was an extraordinarily busy year. The trustees also would like to thank and congratulate the charity's staff, expertly led by Centre Manager Pippa, for their hard work and dedication. 

## **FUNDRAISING** 

The Centre is wholly dependent on fundraising, donations, volunteers and grants to provide its vital services. Fundraising was monitored by the trustees throughout the year to help ensure fundraising objectives were achieved. 

Fundraising continued to be a challenge in 2023 following the adverse impact of 2020-2022. But the patience and the willingness to adapt has allowed the charity to succeed in another very difficult year. 

The trustees would like to thank everyone who supported the charity in 2023; the success of the year is a result of everyone who joined our services, donated, fundraised and volunteered. The trustees also would like to thank and congratulate the charity’s staff, expertly led by Centre Manager Pippa, for their hard work and dedication. 

The trustees continued to meet monthly in response to the circumstances and to provide support. 

## **Contribution of volunteers** 

The charity is incredibly fortunate to have the support of over 100 regular volunteers who support the day-to-day running of the Centre and the numerous events/collections across the year. They bring an invaluable amount of experience, enthusiasm and positivity to the charity. The trustees are very grateful for all who generously provide their time and skills for the benefit of the charity. 


Page 4 



**THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED TRUSTEES’ REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **FINANCIAL REVIEW** 

Over the year the excess of expenditure over income was by £59,826. Cash and cash equivalents at the start of the year were £448,696 and £390,527 at the end of the year. 

The charity is responding to the requirement to generate increased financial support to meet current needs, as well as creating a structure to achieve sustainability over the longer term. 

The charity has always prioritised a mixed fundraising programme that offers security, reduces risk, and generates appropriate levels of unrestricted income. Recognising the importance of robust income to fulfil the charity’s ambitions, the Trustees are carefully investing in fundraising. 

The Trustees wish to thank each individual and organisation who supported the charity in 2023 and particularly want to express our thanks to: 

- AbbVie 

- Berkshire Community Foundation 

- Bradfield College Golf Club 

- Buchanan Programme & Mark Frew 

- Centrica 

- Colefax Charitable Trust 

- Co-op Local Community Fund 

- Crowdfunder and everyone who donated 

- Doris Field 

- Englefield Trust 

- Gerald Palmer Eling Trust 

- Good Exchange and everyone who donated via the website 

- Greenham Trust 

- Haines Hill Charitable Trust 

- Harrison Solicitors 

- Louis Baylis (Maidenhead Advertiser) Charitable Trust 

- National Lottery Community Fund 

- Orr Mactintosh Foundation 

- Pangbourne Rotary Club 

- Prince Philip Trust Fund 

- Reading St Laurence Charitable Trust 

- Sarah Browning 

- Schreier Foundation 

- Screwfix Foundation 

- Sir Jules Thorn Grant 

- The Blakemore Foundation 

- The Edward Gosling Trust 

- The February Foundation 

- The Hospital Saturday Fund 

- The Invesco Cares Foundation 

- Wokingham United Charities 

- Woodroffe Benton 

Page 5 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED TRUSTEES’ REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

Total income for the year was £588,521 (2022: 501,493). 

Total expenditure for the year was £648,347 (2022: £509,977). 

The designated fund balance at the end of 2023 was £71,101 (2022: £71,101) and represents the unspent balance of a legacy the charity has previously received. The legacy was allocated to support initiatives to benefit the Centre over the longer term. 

During the year a legacy of £10,000 was received (2022: £9). We would like to thank Margaret Manley for leaving a Gift to the Centre in her Will. 

## **Reserves policy** 

The Trustees’ ongoing reserves policy is to maintain free reserves (unrestricted net current assets) at between six and twelve months of operating expenditure. At the beginning of 2023 free reserves, based on the 2023 budget, represented approximately 4.7 months’ running costs. 

At the end of 2023 free reserves, based on the 2024 budgeted expenditure (cash flow basis), should be between £320,193 and £640,385. At December 2023 free reserves stood at £251,583, representing approximately 4.6 months running costs. 

|Total assets<br>Less: Restricted Fund<br>Designated Funds<br>Tangible Fixed Assets held in<br>unrestricted funds|**2023**<br>**2022**<br>977,527<br>1,037,353<br>(280,699)<br>(343,187)<br>(71,101)<br>(71,101)<br>(374,144)<br>(409,865)|
|---|---|
||**251,583**<br>**213,200**|



Funds at bank at the end 2023 stood at £390,527 (end of 2022: £448,696). 

Whilst the current free reserves are below the policy level, the trustees feel confident the charity is in a strong enough position to maintain the current levels of services. The situation will be carefully monitored. 

Page 6 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED TRUSTEES’ REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **PLANS FOR FUTURE PERIODS** 

A key ongoing requirement for MS Support is consistency of service and one of the charity’s principal goals is to maintain the services offered, both online and in person. 

In addition the charity intends to 

- Celebrate the 40[th] anniversary of the charity in 2024/2025 

- Recruit Trustees with expertise in finance and fundraising 

- Invest in our physiotherapy and fundraising teams to meet the needs of our members. 

- Explore ways to improve sustainability, reduce running costs and the impact on the environment. 

- Increase the awareness of the presence of the charity in the local area we serve. 

## **REFERENCE AND ADMINISTRATIVE INFORMATION** 

Charity Name: The Berkshire Multiple Sclerosis Therapy Centre Limited 

Charity registration number: 800419 

Company registration number:  2270807 

Registered Office and Bradbury House operational address: 23a August End Brock Gardens Reading, Berkshire RG30 2JP 

## **Directors and Trustees** 

Mr P Bowsher (resigned 15 June 2023) Mr D Coe                                  Treasurer Mr M Farnell                             Secretary (resigned 15 June 2023) Mr I Langrish (resigned 15 June 2023) Mr D Robson (resigned 15 June 2023) Mr P Shambrook Ms P Tillson Mr N Dawkins                           Chairman Ms Sue Brown (appointed 20 April 2023) Mr Gregg Burgess-Salisbury (appointed 15 June 2023 Ms Imogen Fletcher (appointed 15 June 2023) Ms Daniela Hanuskova (appointed 15 June 2023) Mr Nick Webb (appointed 15 June 2023) Ms Ros Hatt (appointed 15 June 2023) Mr Craig Thomson (appointed 15 June 2023; resigned 18 July 2023) Mr Ashley Harrison (appointed 19 October 2023) 

## **Senior Management Team** 

Ms P Vincent Cooke Centre Manager Mrs A Hall Physiotherapy Manager Miss S Harper Fundraising Manager 

## **Independent Examiners** 

Crowe U.K. LLP, Aquis House, 49–51 Blagrave Street, Reading, Berkshire, RG1 1PL 

Page 7 



**THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED TRUSTEES’ REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **Bankers** 

CAF Bank Ltd, 25 Kings Hill Avenue, Kings Hill, West Malling, Kent ME19 4JQ 

## **STRUCTURE, GOVERNANCE AND MANAGEMENT** 

## **Governing Document** 

The Berkshire Multiple Sclerosis Therapy Centre Limited (the charity) is a company limited by guarantee (company number 2270807) and is a registered charity (charity number 800419). 

The charity was established under a Memorandum of Association which established the objects and powers of the charitable company and is governed under its Articles of Association. In the event of the company being wound up members are required to contribute an amount not exceeding £1. 

## Organisational Structure 

The charity is managed by the Trustee Management Committee comprising the company directors and meets at least quarterly. The committee sets the strategic direction and policy of the charity, agrees an annual budget, and monitors performance against the budget. 

All members of the Trustee Management Committee give their time voluntarily. Committee members may benefit from the charity’s MS services on the same terms as other beneficiaries. 

Certain functional responsibilities (eg personnel, IT, therapies, fundraising) have been delegated to sub committees, who report to the Trustee Management Committee on their activities. 

Day to day management of the charity is delegated to the Centre Manager – including supervision of the staff and ensuring that the team continues to develop skills and working arrangements in line with good practice and ensuring the Centre premises are properly serviced and maintained. 

The Physiotherapy Manager is responsible for the direction and supervision of the physiotherapy team, the maintenance of recognized treatment standards, evaluating new treatment opportunities and ongoing training. 

The Fundraising Manager is responsible for managing relationships with potential financial supporters, the submission of applications for donations and grants and promoting fundraising event initiatives. 

Salaries are reviewed annually, generally with reference to the pay scales of the National Joint Council for Local Government Services. 

The trustees consider that the Key Management personnel are the trustees together with the Centre Manager, the Physiotherapy Manager and the Fundraising Manager. 

## Recruitment and Appointment of Management Committee 

Trustee Management Committee members (trustees) must be ordinary members of the company. They are appointed by election at each Annual General Meeting of the charity, provided that in advance of the meeting they have been proposed by another ordinary member and are willing to be elected. 

The officers of the Company – the Chairman, Treasurer and Secretary – are Trustee Management Committee members and are also appointed by election at each Annual General Meeting. The committee may appoint any of their number during the year to fill a casual vacancy among the officers. Such officers hold office until the next following Annual General Meeting 

Page 8 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED TRUSTEES’ REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## Trustee Induction and Training 

New trustees are briefed on the objectives and activities of the charity and the environment within which it operates. 

The policies and procedures of the charity have been documented. These are updated on a cyclical basis. All trustees are required to familiarise themselves with the charity’s policies and procedures. 

## Risk Management 

The trustees have conducted a review of the risks to which the charity is exposed, and assessed their relative significance. These have been recorded within the policies and procedures documentation. Where appropriate, systems and procedures have been established to mitigate the risks the charity faces. 

The principal risks to the charity are considered to be those concerning fund raising, financial internal controls, quality of service delivery and the health and safety of staff, volunteers, clients and visitors to the Centre. 

As regards fundraising, the risk is the adverse fluctuation of financial resources raised during the year. In the longer term this would place a financial strain upon the charity. The charity has developed a diversified range of financial resources to help mitigate this risk. The fundraising strategy is overseen by the Trustees, and actual financial performance is monitored on a monthly basis. Good relationships are maintained with a large pool of volunteers who are able to support the public collections and events programme. 

Financial internal controls include the division of duties. The risk of fraudulent appropriation of the charity’s financial resources is mitigated by the requirement that all financial transactions require dual authorization. 

The quality of service delivery is underpinned by qualified physiotherapy personnel, training programmes to help maintain professional standards and equipment maintenance schedules that comply with manufacturers’ specifications. The Physiotherapy Manager is responsible for the maintenance of recognized treatment standards and evaluating new treatment opportunities. These measures are in place to help ensure that service delivery meets recognized standards and benefits users. 

Procedures are in place to ensure compliance with the health and safety of staff, volunteers, clients and visitors to the Centre. Procedures in place include periodic fire alarm tests, Centre access security and regular maintenance of plant and equipment (including lifting equipment, and hygiene). These procedures are periodically reviewed to ensure that they continue to meet the needs of the charity. 

## **Responsibilities of the Trustees** 

The Trustees (who are also directors of The Berkshire Multiple Sclerosis Therapy Centre Limited for the purposes of company law) are responsible for preparing the Trustees’ Annual Report and the financial statements in accordance with applicable law and United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards). 

Company law requires the Trustees to prepare financial statements for each financial year. Under company law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the Trustees are required to: 

- select suitable accounting policies and then apply them consistently; 

- observe the methods and principles in the Charities SORP; 

- make judgments and estimates that are reasonable and prudent; 

Page 9 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED TRUSTEES’ REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

- state whether applicable UK accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements; and 

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in business. 

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charitable company’s transactions, disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006 and the provisions of the charity’s constitution. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

## Section 172 Statement 

In line with the duties placed on them by section 172 of the Companies Act 2006, the Trustees, as directors of the company, have acted, in good faith, in the way they consider to be most likely to promote the success of the charity and achieve its charitable purposes. This includes placing the needs of the charity’s beneficiaries at the heart of all that they do and focusing on insights-led decision making. All their activities and services are coproduced with employees, volunteers and people affected by MS. 

This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies. 

Approved by the trustees on                                                 2024 and signed on their behalf by: 

**Neil Dawkins** Trustee 

Page 10 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED STATEMENT OF FINANCIAL ACTIVITIES** 

## _**(INCORPORATING AN INCOME AND EXPENDITURE ACCOUNT)**_ 

## **YEAR ENDED 31 DECEMBER 2023** 

|Notes<br>**Income and endowments from:**<br>**Donations & legacies**<br>Donations & subscriptions<br>3<br>Legacies<br>Grants receivable<br>4<br>**Charitable activities**<br>Payments for equipment<br>7<br>Other income<br>8<br>**Other trading activities**<br>Fundraising activities<br>5<br>Treatments to those without MS<br>Electricity – Feed in Tariff<br>Shop activities<br>Rent received<br>6<br>**Investments**<br>9<br>**Total**<br>**Expenditure on:**<br>**Raising funds**<br>Fundraising activities<br>10<br>Shop activities<br>**Charitable activities**<br>Cost of activities in furtherance<br>of the charity’s objects<br>11<br>**Total**<br>**Net expenditure**<br>22<br>Transfers between funds<br>**NET MOVEMENT IN FUNDS FOR YEAR**<br>**Funds at the start of the year**<br>**Funds at the end of the year**|**Unrestricted**<br>**Funds**<br>**2023**<br>**£**<br>275,115<br>10,000<br>16,250<br>1,000<br>-<br>76,489<br>6,605<br>2,829<br>7,089<br>-<br>10,928<br>406,305<br>141,600<br>6,110<br>255,933<br>403,643<br>2,662<br>-<br>2,662<br>694,166<br>696,828|**Restricted**<br>**Funds**<br>**2023**<br>**£**<br>182,216<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>182,216<br>18,000<br>-<br>226,704<br>244,704<br>(62,488)<br>-<br>(62,488)<br>343,187<br>280,699|**Total**<br>**Funds**<br>**2023**<br>**£**<br>**457,331**<br>**10,000**<br>**16,250**<br>**1,000**<br>**-**<br>**76,489**<br>**6,605**<br>**2,829**<br>**7,089**<br>**-**<br>**10,928**<br>**588,521**<br>**159,600**<br>**6,110**<br>**482,637**<br>**648,347**<br>**(59,826)**<br>**-**<br>**(59,826)**<br>**1,037,353**<br>**977,527**|_Total_<br>_Funds_<br>_2022_<br>_£_<br>_403,109_<br>_9_<br>_28,630_<br>_879_<br>_-_<br>_57,560_<br>_2,040_<br>_2,307_<br>_3,260_<br>_-_<br>_3,699_|
|---|---|---|---|---|
|||||_501,493_|
|||||_124,061_<br>_3,356_<br>_382,560_|
|||||_509,977_|
|||||_(8,484)_<br>_-_<br>_(8,484)_<br>_1,045,837_<br>_1,037,353_|



The notes on pages 13 to 28 form part of these accounts 

Page 11 



**THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED BALANCE SHEET** 

## **31 DECEMBER 2023 Company Number 2270807** 

|Notes<br>**FIXED ASSETS**<br>Tangible fixed assets<br>12<br>**CURRENT ASSETS**<br>Stocks<br>13<br>Debtors<br>14<br>Cash at bank and in hand<br>**CREDITORS**: Amounts falling due within<br>one year<br>15<br>**NET CURRENT ASSETS**<br>**TOTAL NET ASSETS**<br>**FUNDS**<br>**Unrestricted Funds**<br>General funds<br>20<br>Designated funds<br>20<br>**Restricted funds**<br>19<br>18|**2,060**<br>**17,273**<br>**390,527**<br>**409,860**<br>**(67,707)**|**2023**<br>**£**<br>**635,374**<br>**342,1543**<br>**977,527**<br>**625,727**<br>**71,101**<br>**280,699**<br>**977,527**|_2022_<br>_£_<br>_697,565_<br>_3,329_<br>_30,446_<br>_448,696_<br>_482,471_<br>_(142,683)_<br>_339,788_<br>_1,037,353_<br>_623,065_<br>_71,101_<br>_343,187_<br>_1,037,353_|
|---|---|---|---|



The trustees consider that the company is entitled to exemption from the requirement to have an audit under the provisions of Section 477 of the Companies Act 2006 (“the Act”) and members have not required the company to obtain an audit of its accounts for the period in question in accordance with Section 476 of the Act.  The trustees acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with Section 386 of the Act, and for preparing financial statements which give a true and fair view of the state of affairs of the company as at 31 December 2023 and of its deficit for the period then ended in accordance with the requirements of Sections 394 and 395 of the Act, and which otherwise comply with the requirements of the Companies Act 2006 relating to the financial statements so far as applicable to the company. 

The financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006. 

These financial statements were approved and authorised for issue by the Board and were signed on its behalf on                                2024 

**Neil Dawkins D R Coe** Trustee Trustee 

The notes on pages 13 to 28 form part of these accounts 

Page 12 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED CASH FLOW STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2023** 

|**2023**<br>**£**<br>**Cash flows from operating activities**<br>Net cash provided by operating activities (see below)<br>**(69,097)**<br>**Cash flows from investing activities**<br>Bank interest received<br>**10,928**<br>Purchase of fixed assets<br>**-**<br>Net cash (used in)/provided by investing activities<br>**10,928**<br>Change in cash and cash equivalents in reporting period<br>**(58,169)**<br>**Cash and cash equivalents at the beginning of the reporting**<br>**period**<br>**448,696**<br>Cash and cash equivalents at the end of the reporting period<br>**390,527**<br>**Reconciliation of net income to net cash flow from operating activities**<br>**2023**<br>**£**<br>Net expenditure<br>**(59,826)**<br>**Adjustments for**<br>Depreciation<br>**62,191**<br>Interest received<br>**(10,928)**<br>Decrease/(increase) in stock<br>**1,269**<br>Decrease/(increase) in Debtors<br>**13,173**<br>Increase/(decrease) in Creditors<br>**(74,976)**<br>**(69,097)**<br>**Analysis and movement of Net Debt**<br>_2022_<br>_£_<br>**Cash flow**<br>**£**<br>**2023**<br>**£**<br>Cash in hand<br>_448,696_<br>**(58,169)**<br>**390,527**|_2022_<br>_£_<br>_21,778_<br>_3,699_<br>_(12,530)_<br>_(8,831)_|
|---|---|
||<br>_12,947_<br>_435,749_<br>_448,696_<br>_2022_<br>_£_<br>_(8,484)_<br>_66,649_<br>_(3,699)_<br>_(949)_<br>_(13,132)_<br>_(18,607)_<br>_21,778_|



Page 13 



**THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS** 

**FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **1. COMPANY INFORMATION** 

The principal activity of the charity is to aid and improve the condition of those living with Multiple Sclerosis.  The incorporated charity (registered number 2270807 and charity number 800419) is domiciled in the UK.  The address of the registered office Bradbury House, 23a August End, Brock Gardens, Reading, Berkshire, RG30 2JP. 

The Berkshire Multiple Sclerosis Therapy Centre Limited is a private company limited by guarantee with no share capital. Each member’s liability would be limited to an amount not exceeding £1 in the event of the charity winding up. 

## **2. ACCOUNTING POLICIES** 

## **a) Basis of accounting** 

The accounts have been prepared in accordance with the Charities SORP (FRS102) applicable to charities preparing their accounts in accordance with the Financial Reporting Standards applicable in the UK and Republic of Ireland and the Charities Act 2011 and UK Generally Accepted Practice as it applies from 1 January 2015. 

The accounts have been prepared to give a ‘true and fair’ view and have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a ‘true and fair view’.  This departure has involved following Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102). 

The Berkshire Multiple Sclerosis Therapy Centre meets the definition of a public benefit entity under FRS 102.  Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy note. 

## **b) Critical accounting judgements and key sources of estimation uncertainty** 

In the application of the charity’s accounting policies, which are described in note 2, trustees are required to make judgements, estimates and assumptions about the carrying value of assets and liabilities that are not readily apparent from other sources.  The estimation and underlying assumptions are based on historical experience and other factors that are considered to be relevant.  Actual results may differ from these estimates. 

The estimates and underlying assumptions are reviewed on an on-going basis.  Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of revision and future periods if the revision affects the current and future periods. 

In the view of the trustees, no assumptions concerning the future or estimation uncertainty affecting the assets and liabilities at the balance sheet date are likely to result in a material adjustment to their carrying amounts in the next financial year. 

Page 14 



**THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **2. ACCOUNTING POLICIES (CONTINUED)** 

## **c) Financial Instruments** 

The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments.  Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value. 

## **d)** 

## **Income** 

All incoming resources are included in the statement of financial activities when the charity is entitled to the income, receipt is probable, and the amount can be quantified with reasonable accuracy. 

The following specific policies are applied to particular categories of income: 

- Voluntary income is received by way of grants, donations and gifts and is included in full in the Statement of Financial Activities when receivable. Grants, where related to performance and specific deliverables, are accounted for as the charity earns the right to consideration by its performance. 

- Donated services and facilities are included at the value to the charity where this can be quantified. The value of services provided by volunteers has not been included in these accounts. 

- Items donated for resale through the charity’s shop are included as incoming resources within activities for generating funds when they are sold.  Recommended contributions from those without MS are payable on receipt of treatment and accounted for at that date. 

- Investment income is included when receivable. 

- Incoming resources from charitable trading activity are accounted for when earned. 

## **e) Expenditure** 

Expenditure is recognized on an accrual basis as each liability is incurred. 

Raising funds comprise the costs associated with attracting voluntary income and the costs of fundraising activities. 

Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them. 

Charitable expenditure is reported under two sub headings: 

- Cost of activities in furtherance of charity’s objects – comprising the cost of  professional personnel and treatment equipment; 

- Support costs - comprising the cost of staff supporting professional personnel, utilities (i.e. heat, light, water, telephone) and a proportion of Centre management and office costs. 

All costs are allocated between the expenditure categories of the Statement of Financial Activities on a basis which is intended to reflect the use of each resource. Costs relating to a particular activity are allocated directly; others are apportioned on an appropriate basis as set out in Note 17. 

Page 15 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **2. ACCOUNTING POLICIES (CONTINUED)** 

## **f) Capitalisation of Fixed Assets and Depreciation** 

All expenditure on items that are intended for continued use by the charity on a long term basis to generate funds and provide services to members are capitalised as fixed assets (except all IT software, and expenditure below £1,000, which is recognised in the Statement of Financial Activities in the year of purchase). 

Depreciation is provided on all tangible fixed assets in use, at rates calculated to write off the cost of each asset, less estimated residual value of each asset over its expected useful life, as follows: 

Buildings - over 50 years Fixtures, fittings & equipment (other than IT equipment) - over 10 years IT Equipment - over 5 years 

## **g) Stocks** 

Stocks are stated at the lower of cost and net realisable value. 

## **h) Fund Accounting** 

- Unrestricted funds are available for use at the discretion of the trustees in furtherance of the general objectives of the charity. 

- Designated funds are unrestricted funds earmarked by the Trustees when there is a specific and authorized commitment on the part of the charity. The level of the fund is set to match the Trustees’ estimate of the outstanding commitment at any given time. 

- Restricted funds represent incoming resources in respect of which the donor/grantors concerned have specified the purposes to which they must be applied. Where attributable expenditure exceeds restricted income received, a transfer from unrestricted funds to restricted funds is made to cover the excess. Restricted income not spent in any year is carried forward in the relevant fund. 

## **i) Debtors** 

Trade and other debtors are recognised at the settlement amount due after any trade discount offered.  Prepayments are valued at the amount prepaid after taking account of any trade discounts due. 

## **j) Creditors and provisions** 

Creditors and provisions are recognised when the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. 

Page 16 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **2. ACCOUNTING POLICIES (CONTINUED)** 

## **k) Cash and cash equivalents** 

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value. 

## **l) Pensions** 

The charity contributes to the personal pension plans of employees.  Contributions are charged to the Statement of Financial Activities as they fall due.  Total contributions in the year were £30,301 _(2022: £23,482)._ There were no outstanding contributions at the balance sheet date _(2022: £nil)._ 

## **3. DONATIONS AND SUBSCRIPTIONS** 

|Membership subscriptions<br>_Donations:_<br>Individuals<br>Gift aid tax reclaimed<br>Charitable trusts<br>Companies<br>Voluntary groups|**2023**<br>**£**<br>**6,618**<br>**128,415**<br>**23,107**<br>**261,416**<br>**36,385**<br>**1,390**<br>**457,331**|_2022_<br>_£_<br>_5,972_<br>_87,075_<br>_15,447_<br>_254,573_<br>_38,506_<br>_1,536_|
|---|---|---|
|||_403,109_|



Page 17 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **4. GRANTS RECEIVABLE** 

|**4.**<br>**GRANTS RECEIVABLE**|||||
|---|---|---|---|---|
|Binfield Parish Council<br>Bracknell Forest<br>Bracknell Town Council<br>Charvil Parish Council<br>Crowthorne Parish Council<br>Earley Town Council<br>Henley Town Council<br>HMRC – National Insurance<br>Holybrook Parish Council<br>Hurst Parish Council<br>Padworth Parish Council<br>Pangbourne Parish Council<br>Purley Parish Council<br>Reading Borough Council<br>Reading BC – COVID-19 Small Business Grant<br>Shinfield Council<br>Speen Parish Council<br>Tadley Town Council<br>Theale Parish Council<br>Warfield Parish Council<br>Wargrave Parish Council<br>Winkfield Parish Council<br>Wokingham Without Parish Council<br>Woodley Town Council<br>**5.**<br>**FUNDRAISING ACTIVITIES – INCOMING RESOURCES**<br>Activities<br>Gift Aid tax reclaimed<br>Public collections<br>**6.**<br>**RENT RECEIVED**<br>Tenancy||**2023**<br>**£**<br>**-**<br>**-**<br>**1,500**<br>**100**<br>**650**<br>**800**<br>**-**<br>**5,000**<br>**500**<br>**-**<br>**100**<br>**-**<br>**500**<br>**5,875**<br>**-**<br>**-**<br>**300**<br>**-**<br>**-**<br>**450**<br>**-**<br>**-**<br>**475**<br>**-**<br>**16,250**<br>**2023**<br>**£**<br>**66,345**<br>**270**<br>**9,874**<br>**76,489**<br>**2023**<br>**£**<br>**-**<br>**-**||_2022_<br>_£_<br>_500_<br>_5,000_<br>_1,400_<br>_-_<br>_550_<br>_750_<br>_1,000_<br>_5,000_<br>_-_<br>_250_<br>_-_<br>_350_<br>_-_<br>_5,850_<br>_4,125_<br>_850_<br>_255_<br>_650_<br>_250_<br>_400_<br>_200_<br>_500_<br>_500_<br>_250_<br>_28,630_<br>_2022_<br>_£_<br>_49,537_<br>_-_<br>_8,023_<br>_57,560_<br>_2022_<br>_£_<br>_-_<br>_-_|
||||||
||||||



Page 18 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

|**7.**<br>**PAYMENTS FOR USE OF EQUIPMENT**<br>Masks for Oxygen Therapy<br>FES Equipment on Loan<br>**8.**<br>**OTHER INCOME**<br>Student placement receipts<br>Research work<br>**9.**<br>**INVESTMENT INCOME**<br>Bank interest<br>**10.**<br>**FUNDRAISING ACTIVITIES – RESOURCES EXPENDED**<br>Direct costs of events<br>Staff and other indirect costs<br>Allocation of support costs (See Note 17)|**2023**<br>**£**<br>**1,000**<br>**-**<br>**1,000**<br>**2023**<br>**£**<br>**-**<br>**-**<br>**-**<br>**2023**<br>**£**<br>**10,928**<br>**10,928**<br>**2023**<br>**£**<br>**16,585**<br>**89,163**<br>**53,852**<br>**159,600**|_2022_<br>_£_<br>_879_<br>_-_<br>_879_<br>_2022_<br>_£_<br>_-_<br>_-_<br>_-_<br>_2022_<br>_£_<br>_3,699_<br>_3,699_<br>_2022_<br>_£_<br>_11,397_<br>_67,093_<br>_45,571_<br>_124,061_|
|---|---|---|



Page 19 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED** 

# **NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **11. COST OF ACTIVITIES IN FURTHERANCE OF THE CHARITY’S OBJECTS** 

|_Direct costs:_<br>Staff<br>Training and recruitment<br>Equipment and<br>consumables<br>Masks<br>FES Equipment<br>Info Day costs<br>Allocation of support costs<br>(see note 17)<br>_Direct costs:_<br>Staff<br>Training and recruitment<br>Equipment and<br>consumables<br>Masks<br>FES Equipment<br>Info Day costs<br>Allocation of support costs<br>(see note 17)||**Physio-**<br>**therapy**<br>**2023**<br>**£**<br>153,455<br>632<br>18,193<br>-<br>570<br>-<br>57,338<br>230,188<br>_2022_<br>_£_<br>_117,072_<br>_963_<br>_18,495_<br>_-_<br>_423_<br>_-_<br>_50,921_<br>_187,874_||**Oxygen**<br>**therapy**<br>**2023**<br>**£**<br>18,691<br>-<br>12,913<br>5,573<br>-<br>-<br>17,274<br>54,451<br>_2022_<br>_£_<br>_17,488_<br>_69_<br>_10,272_<br>_1,435_<br>_-_<br>_-_<br>_14,810_<br>_44,074_|**Counselling**<br>**2023**<br>**£**<br>21,872<br>-<br>-<br>-<br>-<br>-<br>4,935<br>26,807<br>_2022_<br>_£_<br>_15,732_<br>_-_<br>_-_<br>_-_<br>_-_<br>_-_<br>_4,231_<br>_19,963_||**Yoga**<br>**2023**<br>**£**<br>6,959<br>-<br>-<br>-<br>-<br>-<br>2,468<br>9,427<br>_2022_<br>_£_<br>_6,188_<br>_-_<br>_-_<br>_-_<br>_-_<br>_-_<br>_2,116_<br>_8,304_|**Chiropody**<br>**2023**<br>**£**<br>9,500<br>-<br>-<br>-<br>-<br>-<br>7,403<br>16,903<br>_2022_<br>_£_<br>_8,400_<br>_-_<br>_-_<br>_-_<br>_-_<br>_-_<br>_6,347_<br>_14,747_||**Art**<br>**therapy**<br>**2023**<br>**£**<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>_2022_<br>_£_<br>_-_<br>_-_<br>_-_<br>_-_<br>_-_<br>_-_<br>_-_|**Complementary**<br>**therapies**<br>**2023**<br>**£**<br>-<br>-<br>-<br>-<br>-<br>-<br>7,403<br>7,403<br>_2022_<br>_£_<br> <br>_-_<br> <br>_-_<br> <br>_-_<br> <br>_-_<br> <br>_-_<br> <br>_-_<br> <br>_6,347_<br> <br>_6,347_|**Support**<br>**Network**<br>**2023**<br>**£**<br>41,364<br>-<br>-<br>-<br>-<br>-<br>96,094<br>137,458<br>_2022_<br>_£_<br>_20,022_<br>_-_<br>_-_<br>_-_<br>_-_<br>_-_<br>_81,229_<br>_101,251_|**Total**<br>**2023**<br>**£**<br>**251,841**<br>**632**<br>**31,106**<br>**5,573**<br>**570**<br>**-**<br>**192,915**<br>**482,637**<br>_2022_<br>_£_<br>_184,902_<br>_1,032_<br>_28,767_<br>_1,435_<br>_423_<br>_-_<br>_166,001_<br>_382,560_|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||||||
||||||||||||<br> <br> <br> <br> <br> <br> <br>|||
|||||||||||_-_||||



Page 20 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **12. TANGIBLE FIXED ASSETS** 

|**Cost**<br>At 1 January 2023<br>Additions<br>**At 31 December 2023**<br>**Depreciation**<br>At 1 January 2023<br>Charge for the year<br>**At 31 December 2023**<br>**Net book value**<br>**At 31 December 2023**<br>_At 31 December 2022_|**Land &**<br>**buildings**<br>**£**<br>825,612<br>-<br>825,612<br>317,048<br>13,212<br>330,260<br>**495,352**<br>_508,564_|**Fixtures,**<br>**fittings &**<br>**equipment**<br>**£**<br>709,488<br>-<br>709,488<br>520,487<br>48,979<br>569,466<br>**140,022**<br>_189,001_|**Total**<br>**£**<br>**1,535,100**<br>**-**<br>**1,535,100**<br>**837,535**<br>**62,191**<br>**899,726**<br>**635,374**<br>_697,565_|
|---|---|---|---|



All fixed assets are used for activities in furtherance of the charity’s objects or in support thereof. 

## **13.** 

## **STOCKS** 

|Goods for sale<br>Masks|**2023**<br>**£**<br>**1,100**<br>**960**<br>**2,060**|_2022_<br>_£_<br>_949_<br>_2,380_<br>_3,329_|
|---|---|---|



Page 21 



**THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **14. DEBTORS** 

|Other debtors<br>Insurance claim<br>Prepayments<br>**REDITORS**: Amounts falling due within one year<br>Trade creditors<br>Other creditors<br>Taxation and social security<br>Accruals and deferred income|**2023**<br>**£**<br>**2,540**<br>**-**<br>**14,733**<br>**17,273**<br>**2023**<br>**£**<br>**7,852**<br>**435**<br>**6,910**<br>**52,510**<br>**67,707**|_2022_<br>_£_<br>_1,518_<br>_14,133_<br>_14,795_<br>_30,446_<br>_2022_<br>_£_<br>_12,472_<br>_-_<br>_5,195_<br>_125,016_<br>_142,683_|
|---|---|---|



**15. CREDITORS** : Amounts falling due within one year 

## **16. STAFF NUMBERS AND COSTS** 

The average number of persons employed by the charity during the year, analysed by category, was as follows:- 

|Direct charitable activities<br>Fundraising<br>Management and administration<br>he aggregate payroll costs of these persons were as follows:-<br>Gross wages and salaries<br>Employer’s national insurance costs<br>Employer’s pension costs|**2023**<br>**5**<br>**3**<br>**2**<br>**2023**<br>**£**<br>**302,007**<br>**27,032**<br>**30,201**<br>**359,240**|_2022_<br>_5_<br>_3_<br>_2_<br>_2022_<br>_£_<br>_232,320_<br>_21,560_<br>_23,482_<br>_277,362_|
|---|---|---|



The aggregate payroll costs of these persons were as follows:- 

No employee received emoluments in excess of £60,000 _(2022: £nil)._ 

No remuneration was received by any of the trustees _(2022: £nil)_ .  No expenses were reimbursed to any trustees _(2022: £nil)._ 

There have been no related party transactions during the year that require disclosure. 

Remuneration of key management personnel (including Employers NIC and Employers pension contributions) was £150,746 ( _2022: £142,643_ ) 

Page 22 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **17.** 

## **SUPPORT COSTS** 

Support costs have been allocated on the basis of estimates of the proportion of each expense that is utilised by each of the output activities, as follows:- 

|**2023**||**Total**|**Fundraising**|**Physio-**|**Oxygen**|**Counselling**|**Yoga**||**Chiropody**|**Complementary**|**Network/**|
|---|---|---|---|---|---|---|---|---|---|---|---|
|||||**therapy**|**therapy**|||||**therapies**|**advice**|
|||**%**|**%**|**%**|**%**|**%**|**%**||**%**|**%**|**%**|
|Management and admin||||||||||||
|staff costs||100|20|20|7|2||1|3|3|44|
|Office costs||100|32|20|7|2||1|3|3|32|
|Information and publicity|)|||||||||||
|Insurance and business|)|100|20|20|7|2||1|3|3|44|
|consultancy|)|||||||||||
|Bank charges|)|||||||||||
|Utilities and hygiene||||||||||||
|costs|)|||||||||||
|Buildings – maintenance|)|100|20|30|7|2||1|3|3|34|
|and depreciation|)|||||||||||
|Governance||100|20|20|7|2||1|3|3|44|
|_2022 comparatives_||**_Total_**|**_Fundraising_**|**_Physio-_**|**_Oxygen_**|**_Counselling_**|**_Yoga_**||**_Chiropody_**|**_Complementary_**|**_Network/_**|
|||||**_therapy_**|**_therapy_**|||||**_therapies_**|**_advice_**|
|||**_%_**|**_%_**|**_%_**|**_%_**|**_%_**|**_%_**||**_%_**|**_%_**|**_%_**|
|_Management and admin_||||||||||||
|_staff costs_||_100_|_20_|_20_|_7_|_2_||_1_|_3_|_3_|_44_|
|_Office costs_||_100_|_32_|_20_|_7_|_2_||_1_|_3_|_3_|_32_|
|_Information and publicity_|_)_|||||||||||
|_Insurance and business_|_)_|_100_|_20_|_20_|_7_|_2_||_1_|_3_|_3_|_44_|
|_consultancy_|_)_|||||||||||
|_Bank charges_|_)_|||||||||||
|_Utilities and hygiene_||||||||||||
|_costs_|_)_|||||||||||
|_Buildings – maintenance_|_)_|_100_|_20_|_30_|_7_|_2_||_1_|_3_|_3_|_34_|
|_and depreciation_|_)_|||||||||||
|_Governance_||_100_|_20_|_20_|_7_|_2_||_1_|_3_|_3_|_44_|



Page 23 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **17. SUPPORT COSTS (continued)** 

|Management and admin<br>staff costs<br>Office costs<br>Information and publicity<br>Insurance and business<br>consultancy<br>Bank charges<br>Utilities and hygiene<br>costs<br>Buildings – maintenance<br>and depreciation<br>Governance|**Total**<br>**2023**<br>**73,169**<br>**37,491**<br>**14,081**<br>**21,436**<br>**5,350**<br>**19,022**<br>**60,824**<br>**15,394**<br>**246,767**|**Fundraising**<br>**2023**<br>14,634<br>11,997<br>2,816<br>4,287<br>1,070<br>3,804<br>12,165<br>3,079<br>53,852|**Physio-**<br>**therapy**<br>**2023**<br>14,634<br>7,498<br>2,816<br>4,287<br>1,070<br>5,707<br>18,247<br>3,079<br>57,338|**Oxygen**<br>**therapy**<br>**2023**<br>5,122<br>2,624<br>986<br>1,501<br>375<br>1,331<br>4,258<br>1,077<br>17,274|**Counselling**<br>**2023**<br>1,463<br>750<br>282<br>429<br>107<br>380<br>1,216<br>308<br>4,935|**Yoga**<br>**2023**<br>732<br>375<br>141<br>214<br>54<br>190<br>608<br>154<br>2,468|**Chiropody**<br>**2023**<br>2,195<br>1,125<br>422<br>643<br>160<br>571<br>1,825<br>462<br>7,403|**Complementary**<br>**therapies**<br>**2023**<br>2,195<br>1,125<br>422<br>643<br>160<br>571<br>1,825<br>462<br>7,403|**Network/**<br>**advice**<br>**2023**<br>32,194<br>11,997<br>6,196<br>9,432<br>2,354<br>6,468<br>20,680<br>6,773<br>96,094|_Total_<br>_2022_<br>_61,629_<br>_27,135_<br>_2,198_<br>_17,172_<br>_4,922_<br>_19,194_<br>_66,872_<br>_12,450_<br>_211,572_|
|---|---|---|---|---|---|---|---|---|---|---|



Page 24 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **17. SUPPORT COSTS (continued)** 

|Management and admin<br>staff costs<br>Office costs<br>Information and publicity<br>Insurance and business<br>consultancy<br>Bank charges<br>Utilities and hygiene<br>costs<br>Buildings – maintenance<br>and depreciation<br>Governance|**Total**<br>_2022_<br>_£_<br>_61,629_<br>_27,135_<br>_2,198_<br>_17,172_<br>_4,922_<br>_19,194_<br>_66,872_<br>_12,450_<br>_211,572_|**Fundraising**<br>_2022_<br>_£_<br>_12,326_<br>_8,683_<br>_440_<br>_3,434_<br>_985_<br>_3,839_<br>_13,374_<br>_2,490_<br>_45,571_|**Physio-**<br>**therapy**<br>_2022_<br>_£_<br>_12,326_<br>_5,427_<br>_440_<br>_3,434_<br>_984_<br>_5,758_<br>_20,062_<br>_2,490_<br>_50,921_|**Oxygen**<br>**therapy**<br>_2022_<br>_£_<br>_4,314_<br>_1,899_<br>_154_<br>_1,202_<br>_345_<br>_1,344_<br>_4,681_<br>_871_<br>_14,810_|**Counselling**<br>_2022_<br>_£_<br>_1,232_<br>_543_<br>_44_<br>_344_<br>_98_<br>_384_<br>_1,337_<br>_249_<br>_4,231_|**Yoga**<br>_2022_<br>_£_<br>_616_<br>_271_<br>_22_<br>_172_<br>_49_<br>_192_<br>_669_<br>_125_<br>_2,116_|**Chiropody**<br>_2022_<br>_£_<br>_1,849_<br>_814_<br>_66_<br>_515_<br>_148_<br>_576_<br>_2,006_<br>_373_<br>_6,347_|**Complementary**<br>**therapies**<br>_2022_<br>_£_<br>_1,849_<br>_814_<br>_66_<br>_515_<br>_148_<br>_576_<br>_2,006_<br>_373_<br>_6,347_|**Network/**<br>**advice**<br>_2022_<br>_£_<br>_27,117_<br>_8,684_<br>_966_<br>_7,556_<br>_2,165_<br>_6,525_<br>_22,737_<br>_5,479_<br>_81,229_|
|---|---|---|---|---|---|---|---|---|---|



Page 25 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **18. ANALYSIS OF NET ASSETS BETWEEN FUNDS** 

|Tangible fixed assets<br>Current assets<br>Current liabilities<br>_2022 Comparative_<br>_Tangible fixed assets_<br>_Current assets_<br>_Current liabilities_|**Unrestricted**<br>**Funds**<br>**General**<br>**£**<br>**374,144**<br>**319,290**<br>**(67,707)**<br>**625,727**<br>_£_<br>_409,865_<br>_355,883_<br>_(142,683)_<br>_623,065_|**Designated**<br>**Funds**<br>**£**<br>**-**<br>**71,101**<br>**-**<br>**71,101**<br>_£_<br>_-_<br>_71,101_<br>_-_<br>_71,101_|**Restricted**<br>**Funds**<br>**£**<br>**261,230**<br>**19,469**<br>**-**<br>**280,699**<br>_£_<br>_287,700_<br>_55,487_<br>_3242,187_|**Total Funds**<br>**2023**<br>**£**<br>**635,374**<br>**409,860**<br>**(67,707)**<br>**977,527**<br>_£_<br>_697,565_<br>_482,471_<br>_(142,683)_<br>_1,037,353_|
|---|---|---|---|---|



## **19. RESTRICTED FUNDS** 

|Land and buildings<br>Counselling<br>IT - Laptops<br>Nordic Walking Poles<br>Oxygen Therapy<br>Physio Equipment<br>Physio Invacare Hoist<br>Physio plinth<br>Physio Thera chair<br>Physiotherapy<br>Physio Treadmill<br>Refrigerant dryer<br>Resilience Funding (CAF)<br>Support Network<br>Video project<br>Window renewals<br>Yoga<br>Zoom IT Facility|**1**<br>**January**<br>**2023**<br>**£**<br>**274,442**<br>**-**<br>**2,582**<br>**70**<br>**-**<br>**282**<br>**1,459**<br>**843**<br>**3,719**<br>**-**<br>**2,625**<br>**133**<br>**54,288**<br>**-**<br>**-**<br>**-**<br>**-**<br>**2,744**<br>**343,187**|**Incoming**<br>**Resources**<br>**£**<br>**-**<br>**9,609**<br>**-**<br>**-**<br>**2,139**<br>**-**<br>**-**<br>**-**<br>**-**<br>**141,054**<br>**-**<br>**-**<br>**-**<br>**11,563**<br>**5,520**<br>**8,230**<br>**4,101**<br>**-**<br>**182,216**|**Transfer**<br>**£**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Resources**<br>**Expended**<br>**£**<br>**(13,212)**<br>**(9,609)**<br>**(999)**<br>**-**<br>**(2,139)**<br>**-**<br>**(162)**<br>**-**<br>**(666)**<br>**(141,054)**<br>**(375)**<br>**(133)**<br>**(54,288)**<br>**(11,563)**<br>**(5,520)**<br>**-**<br>**(4,101)**<br>**(883)**<br>**(244,704)**|**31**<br>**December**<br>**2023**<br>**£**<br>**261,230**<br>**-**<br>**1,583**<br>**70**<br>**-**<br>**282**<br>**1,297**<br>**843**<br>**3,053**<br>**-**<br>**2,250**<br>**-**<br>**-**<br>**-**<br>**-**<br>**8,230**<br>**-**<br>**1,861**<br>**280,699**|
|---|---|---|---|---|---|



Page 26 



## **THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **19. RESTRICTED FUNDS (continued)** 

|_2022 Comparative_<br>Land and buildings<br>Counselling<br>IT - Laptops<br>Nordic Walking Poles<br>Oxygen Therapy<br>Physio Equipment<br>Physio Invacare Hoist<br>Physio plinth<br>Physio Thera chair<br>Physiotherapy<br>Physio Treadmill<br>Refrigerant dryer<br>Resilience Funding (CAF)<br>Support Network<br>Yoga<br>Zoom IT Facility<br>**NRESTRICTED FUNDS**<br>**Designated funds**<br>Legacy fund<br>**General funds**<br>_2021 Comparative_<br>_Designated funds_<br>_Legacy fund_<br>_General funds_|**1**<br>**January**<br>**Incoming**<br>**Resources**<br>**Transfer**<br>**Resources**<br>**Expended**<br>**31**<br>**December**<br>**2022**<br>**2022**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>_287,654_<br>_-_<br>_-_<br>_(13,202)_<br>_274,442_<br>_-_<br>_10,000_<br>_-_<br>_(10,000)_<br>_-_<br>_3,581_<br>_-_<br>_-_<br>_(999)_<br>_2,582_<br>_70_<br>_-_<br>_-_<br>_-_<br>_70_<br>_-_<br>_7,064_<br>_-_<br>_(7,064)_<br>_-_<br>_2_<br>_280_<br>_-_<br>_-_<br>_282_<br>_1,621_<br>_-_<br>_(162)_<br>_1,459_<br>_843_<br>_-_<br>_-_<br>_-_<br>_843_<br>_4,386_<br>_-_<br>_-_<br>_(667)_<br>_3,719_<br>_-_<br>_109,849_<br>_-_<br>_(109,849)_<br>_-_<br>_3,000_<br>_-_<br>_-_<br>_(375)_<br>_2,625_<br>_266_<br>_-_<br>_-_<br>_(133)_<br>_133_<br>_9,875_<br>_66,587_<br>_(22,174)_<br>_54,288_<br>_-_<br>_500_<br>_-_<br>_(500)_<br>_-_<br>_-_<br>_1,507_<br>_(1,507)_<br>_-_<br>_3,627_<br>_-_<br>_-_<br>_(883)_<br>_2,744_<br>_314,925_<br>_195,787_<br>_-_<br>_(167,525)_<br>_343,187_<br>**1**<br>**January**<br>**Incoming**<br>**Resources**<br>**Transfer**<br>**Resources**<br>**Expended**<br>**31**<br>**December**<br>**2023**<br>**2023**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>**71,101**<br>**-**<br>**-**<br>**-**<br>**71,101**<br>**623,065**<br>**406,305**<br>**-**<br>**(403,643)**<br>**625,727**<br>**694,166**<br>**406,305**<br>**-**<br>**(403,643)**<br>**696,828**<br>_1_<br>_January_<br>_Incoming_<br>_Resources_<br>_Transfer_<br>_Resources_<br>_Expended_<br>_31_<br>_December_<br>_2022_<br>_2022_<br>_£_<br>_£_<br>_£_<br>_£_<br>_£_<br>_71,101_<br>_-_<br>_-_<br>_-_<br>_71,101_<br>_659,811_<br>_305,706_<br>_-_<br>_(342,452)_<br>_623,065_<br>_730,912_<br>_305,706_<br>_-_<br>_(342,452)_<br>_694,166_|**31**<br>**December**<br>**2022**<br>**£**<br>_274,442_<br>_-_<br>_2,582_<br>_70_<br>_-_<br>_282_<br>_1,459_<br>_843_<br>_3,719_<br>_-_<br>_2,625_<br>_133_<br>_54,288_<br>_-_<br>_-_<br>_2,744_|
|---|---|---|
|||_343,187_|



## **20. UNRESTRICTED FUNDS** 

Page 27 



**THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **20. UNRESTRICTED FUNDS (continued)** 

General Funds represent those funds which are unrestricted and not designated for other purposes. 

## **21. CAPITAL COMMITMENTS** 

At 31 December 2023, the company had no capital commitments _(2022: £nil)._ 

## **22. NET EXPENDITURE FOR THE YEAR** 

|**Is stated after charging:-**<br>Depreciation<br>Independent Examination (including irrecoverable VAT)|**2023**<br>**£**<br>**62,191**<br>**5,520**|_2022_<br>_£_<br>_66,649_<br>_4,770_|
|---|---|---|



## **23. FINANCIAL INSTRUMENTS** 

All of the company’s monetary assets and liabilities are basic financial instruments. 

Page 28 



**THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED NOTES TO THE ACCOUNTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023** 

## **24. COMPARATIVE STATEMENT OF FINANCIAL ACTIVITIES** 

|_Income and endowments from:_<br>_Donations and legacies_<br>_Donations & subscriptions_<br>_Legacies_<br>_Grants receivable_<br>_Charitable Activities_<br>_Payments for equipment_<br>_Other income_<br>_Other trading activities_<br>_Fundraising activities_<br>_Treatments to those without MS_<br>_Electricity – Feed in Tariff_<br>_Shop activities_<br>_Rent received_<br>_Investments_<br>_Total_<br>_Expenditure on:_<br>_Raising funds_<br>_Fundraising activities_<br>_Shop activities_<br>_Charitable activities_<br>_Cost of activities in furtherance of the_<br>_charity’s objects_<br>_Total_<br>_Net (expenditure)_<br>_Transfers between funds_<br>_NET MOVEMENT IN FUNDS FOR YEAR_<br>_Funds at the start of the year_<br>_Funds at the end of the year_|_Unrestricted_<br>_Funds_<br>_2022_<br>_£_<br>_207,722_<br>_9_<br>_28,230_<br>_879_<br>_-_<br>_57,560_<br>_2,040_<br>_2,307_<br>_3,260_<br>_-_<br>_3,699_<br>_305,706_<br>_124,061_<br>_3,356_<br>_215.035_<br>_342,452_<br>_(36,746)_<br>_-_<br>_(36,746)_<br>_730,912_<br>_694,166_|_Restricted_<br>_Funds_<br>_2022_<br>_£_<br>_195,387_<br>_-_<br>_400_<br>_-_<br>_-_<br>_-_<br>_-_<br>_-_<br>_-_<br>_-_<br>_-_<br>_195,787_<br>_-_<br>_-_<br>_167,525_<br>_167,525_<br>_28,262_<br>_-_<br>_28,262_<br>_314,925_<br>_343,187_|_Total_<br>_Funds_<br>_2022_<br>_£_<br>_403,109_<br>_9_<br>_28,630_<br>_879_<br>_-_<br>_57,560_<br>_2,040_<br>_2,307_<br>_3,260_<br>_-_<br>_3,699_<br>_501,493_<br>_124,061_<br>_3,356_<br>_382,560_<br>_509,977_<br>_(8,484)_<br>_-_<br>_(8,484)_<br>_1,045,837_<br>_1,037,353_|
|---|---|---|---|



Page 29 



**INDEPENDENT EXAMINERS’ REPORT TO THE TRUSTEES OF THE BERKSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED** 

I report to the charity trustees on my examination of the accounts of the company for the year ended 31 December 2023, which are set out on pages 11 to 29. 

This report is made solely to the charitable company’s trustees, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006 and the charitable company’s trustees as a body in accordance with section 154 of the Charities Act 2011. My independent examiner’s work has been undertaken so that I might state to the charitable company’s trustees those matters I am required to state to them in an independent examiner’s report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the charitable company, the charitable company’s members as a body and the charitable company’s trustees as a body for my independent examiner’s work, for this report, or for the opinions I have formed. 

## **Responsibilities and basis of report** 

As the charity’s trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’). 

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act. 

## **Independent examiner’s statement** 

Since the Company’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies. I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe: 

1. accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or 

2. the accounts do not accord with those records; or 

3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view which is not a matter considered as part of an independent examination; or 

4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. 

Aquis House 49 – 51 Blagrave Street Reading 

Janette Joyce **CROWE U.K. LLP** Chartered Accountants 

Page 30 

